Does SPARSENTAN Cause Fluid retention? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Fluid retention have been filed in association with SPARSENTAN (FILSPARI). This represents 1.6% of all adverse event reports for SPARSENTAN.
51
Reports of Fluid retention with SPARSENTAN
1.6%
of all SPARSENTAN reports
1
Deaths
9
Hospitalizations
How Dangerous Is Fluid retention From SPARSENTAN?
Of the 51 reports, 1 (2.0%) resulted in death, 9 (17.6%) required hospitalization.
Is Fluid retention Listed in the Official Label?
Yes, Fluid retention is listed as a known adverse reaction in the official FDA drug label for SPARSENTAN.
What Other Side Effects Does SPARSENTAN Cause?
Dizziness (521)
Fatigue (448)
Hypotension (377)
Product use in unapproved indication (262)
Nausea (231)
Peripheral swelling (197)
Headache (186)
Pruritus (171)
Blood creatinine increased (145)
Glomerular filtration rate decreased (141)
What Other Drugs Cause Fluid retention?
AMBRISENTAN (3,927)
TREPROSTINIL (3,804)
MACITENTAN (2,861)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,233)
SACUBITRIL\VALSARTAN (2,187)
ADALIMUMAB (1,193)
SELEXIPAG (1,044)
FUROSEMIDE (1,020)
LENALIDOMIDE (1,007)
EPOPROSTENOL (929)
Which SPARSENTAN Alternatives Have Lower Fluid retention Risk?
SPARSENTAN vs SPESOLIMAB-SBZO
SPARSENTAN vs SPIRAMYCIN
SPARSENTAN vs SPIRIVA
SPARSENTAN vs SPIRONOLACTONE
SPARSENTAN vs SPRYCEL